01/11/2026
Our genitourinary team has a new publication out, "Stereotactic Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer: Final Results of a Phase 2b Trial," in European Urology Oncology, that summarizes an important advancement in renal cell carcinoma care.
This Phase 2b trial is the first to prospectively validate sequential SAbR as a disease-control strategy, demonstrating durable control without compromising quality of life. Raquibul Hannan, M.D., Ph.D., Chief of Genitourinary Radiation Oncology Service, is lead author; Robert Timmerman, M.D., is senior author.
Other authors from our Department include: Ryan Assadi, D.O., medical resident; Aurelie Garant, M.D., and David Sher, M.D. 🔗 https://bit.ly/4598Umd